about
Proteomic-Based Approaches for the Study of Cytokines in Lung CancerTyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical ImplicationsCharacterization of the p53 response to oncogene-induced senescence.Exploring the gain of function contribution of AKT to mammary tumorigenesis in mouse models.Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population.Epithelial-to-mesenchymal transition and stem cells in endometrial cancer.MicroRNA-dependent regulation of transcription in non-small cell lung cancer.Efficacy of bortezomib in sarcomas with high levels of MAP17 (PDZK1IP1).Current Challenges in Cancer Treatment.p38α limits the contribution of MAP17 to cancer progression in breast tumors.S-adenosylhomocysteine hydrolase downregulation contributes to tumorigenesis.Down-regulation of spinophilin in lung tumours contributes to tumourigenesis.Stromal signatures in endometrioid endometrial carcinomas.IL-11 and CCL-1: Novel Protein Diagnostic Biomarkers of Lung Adenocarcinoma in Bronchoalveolar Lavage Fluid (BALF).Spinophilin loss contributes to tumorigenesis in vivo.PPP1CA contributes to the senescence program induced by oncogenic Ras.Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors.19P Comparative effectiveness analysis of HSP90 inhibitors in non-small cell lung cancer20P Context-dependent role of FGFR4 in lung tumorogenesisSpinophilin acts as a tumor suppressor by regulating Rb phosphorylationThe FOXO1-miR27 tandem regulates myometrial invasion in endometrioid endometrial adenocarcinomaOsimertinib in EGFR-mutant NSCLC: how to select patients and when to treatNotch inhibition overcomes resistance to tyrosine kinase inhibitors in EGFR-driven lung adenocarcinoma
P50
Q26738539-BB6B7815-CD0F-4C2F-9D90-5E978A431879Q26741318-98938124-0EAA-4F59-8516-897C01B9078DQ33370291-E173447F-5AC5-4FB5-975D-73135937858DQ33533301-8B0903A8-8370-4D44-8095-C8258DAF3395Q33659361-C247551F-7E9B-4D36-9C98-68F9208E57ACQ34813145-4B404305-AFE3-4E2A-BAE8-7822C6D9EFA4Q35119983-5CF60813-594C-4587-A0B8-BC231177CEC3Q37687113-CF1C21D0-21DA-49A4-B07E-F89C3C0907C6Q38829296-76B008C4-101A-45BE-820A-CD1ADE08646EQ39408183-4EB4A3E1-31AA-4B7D-82D8-57F12085B8C5Q42809373-96896BCA-C950-4F19-8C16-D2C2D49A877AQ44627811-6A627E4D-E2BB-4795-BA47-8519303E79CAQ46544116-B7F0B6AA-D574-4A40-9B08-A5A6D0CEFD03Q51571804-03B75D5D-4C1A-4BC6-BB3C-D164B2C404B6Q53240879-22B33BBF-2C1F-46A7-AF65-39059711E250Q53325013-4A9FCE44-A05B-4972-ACC3-33741DBC12DFQ55059319-A463FE08-FA55-408B-8222-8B591BC6398BQ60584716-CCC3E6EF-4CA4-4A78-BBBF-1614777F05E6Q60584717-F2F4EB41-0FB1-4E17-B652-815CD24C0F58Q60584720-8400F7CB-B396-487F-9ADA-53FEF0ACC679Q87709968-B1941510-9B5F-469C-BC42-FEFC4AEA8EE4Q88573784-E8F66F1F-A776-4107-9DC3-C585171A991FQ91034633-FA4FF140-B4FA-4C5D-A60B-D4473BDAF41B
P50
description
researcher ORCID id 0000-0002-2748-2607
@en
wetenschapper
@nl
name
Irene Ferrer
@ast
Irene Ferrer
@en
Irene Ferrer
@es
Irene Ferrer
@nl
type
label
Irene Ferrer
@ast
Irene Ferrer
@en
Irene Ferrer
@es
Irene Ferrer
@nl
prefLabel
Irene Ferrer
@ast
Irene Ferrer
@en
Irene Ferrer
@es
Irene Ferrer
@nl
P106
P21
P31
P496
0000-0002-2748-2607